Article Sidebar
Downloads
Metrics
Main Article Content
Abstract
In Spain during 2010 there were 2225, of which 420 were held in Madrid. (www.ont.es) The number of kidney transplants performed at this hospital since its inception in 1980 is 1740. Proper adherence to immunosuppressive treatment is essential in this type of patient, since non-adherence to treatment can be the cause of loss of the kidney graft; it has been proven how important it is to follow this treatment correctly along with healthy lifestyle habits so that the patient's survival is also improved(1,2,3,4,5,6,7,8,9). Adherence to treatment can be a modifiable cause, where nursing has an important role, intervening actively in the health education of the transplanted patient(1,2,3,4,5,6,7,8), hence, we consider knowing the degree of adherence that our patients with renal transplants have. It is difficult to detect kidney transplant recipients who are not adherent to immunosuppressive treatment, but at the same time it is important to identify them in order to be able to act promptly and consequently, on many occasions, poor compliance with treatment may be suspected, without affirming it until the patient actually recognises it(1,2,3,4,5,6,7,8). Adherence to treatment is due to adequate compliance with immunosuppressive therapy, which includes two concepts: compliance with the dose and form of administration and persistence in the duration of the prescribed treatment (1,2,3,4,5,6,7).
Keywords
Article Details
Copyright (c) 2012 Mª Isabel Durán Muñoz, Teresa Lope Andrea, Mª Rosario Pino Jurado, Elisa Matilla Villar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Author copyright notice
© Authors grant the publisher the non-exclusive licence to publish the work and consent to its use and distribution under the Creative Commons Attribution - NonCommercial 4.0 International (CC BY-NC 4.0) licence. Read the licensing information and the legal text here. This must be expressly stated wherever necessary.
References
- Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosu-ppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005; 59:13-20.
- Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of an immunosu-ppressant therapy adherence barrier instrument. Nephrol Dial Transplant. 2005; 20:181-188.
- Chisholm MA, Lance CE, Mulloy LL. Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients. Am J Health Syst Pharm.2005 Sep 1; 62(17): 1775-1781.
- Chisholm-Burns MA, Spivey CA, Wilks SE. Social support and immunosuppressant therapy adherence among adult renal transplant recipients. Clin Transplant. 2010 May-Jun; 24(3):312-320.
- Wilks SE, Spivey CA, Chisholm-Burns MA. Psy-chometric re-evaluation of the immunosuppressant therapy adherence scale among solid-organ transplant recipients. Journal of Evaluation in Clinical Practice. 2010 Feb; 16(1):64-68.
- Fernandez Lucas M, López Sanchez S, Miranda B, Matesanz R. Adhesión al tratamiento en pacientes receptores de trasplante renal. Estudio multicéntrico español. Nefrología.1998; XVIII: 316-325.
- Nogués Solán X, Sorli Redó ML, Villar García J. Instrumentos de medida de adherencia al tratamiento. Anales de Medicina Interna. 2007;24(3):138-141.
- Barquero Ruano RM, Checa Barambio E, Rodriguez Peña J. Mala adherencia al tratamiento inmunosu-presor de un paciente trasplantado renal. Rev Soc Esp Enferm Nefr.2010 Oct-Dic; 13(4):267-269.
- Butler JA, Roderick P, Mullee M, Mason JC, Peverer RC, Frecuency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review.Transplantation.2004 Mar;77(5):769-776.
References
Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosu-ppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005; 59:13-20.
Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of an immunosu-ppressant therapy adherence barrier instrument. Nephrol Dial Transplant. 2005; 20:181-188.
Chisholm MA, Lance CE, Mulloy LL. Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients. Am J Health Syst Pharm.2005 Sep 1; 62(17): 1775-1781.
Chisholm-Burns MA, Spivey CA, Wilks SE. Social support and immunosuppressant therapy adherence among adult renal transplant recipients. Clin Transplant. 2010 May-Jun; 24(3):312-320.
Wilks SE, Spivey CA, Chisholm-Burns MA. Psy-chometric re-evaluation of the immunosuppressant therapy adherence scale among solid-organ transplant recipients. Journal of Evaluation in Clinical Practice. 2010 Feb; 16(1):64-68.
Fernandez Lucas M, López Sanchez S, Miranda B, Matesanz R. Adhesión al tratamiento en pacientes receptores de trasplante renal. Estudio multicéntrico español. Nefrología.1998; XVIII: 316-325.
Nogués Solán X, Sorli Redó ML, Villar García J. Instrumentos de medida de adherencia al tratamiento. Anales de Medicina Interna. 2007;24(3):138-141.
Barquero Ruano RM, Checa Barambio E, Rodriguez Peña J. Mala adherencia al tratamiento inmunosu-presor de un paciente trasplantado renal. Rev Soc Esp Enferm Nefr.2010 Oct-Dic; 13(4):267-269.
Butler JA, Roderick P, Mullee M, Mason JC, Peverer RC, Frecuency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review.Transplantation.2004 Mar;77(5):769-776.